These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7611316)

  • 1. Visual acuity as a prognostic indicator in stage I macular holes. The Vitrectomy for Prevention of Macular Hole Study Group.
    Kokame GT; de Bustros S
    Am J Ophthalmol; 1995 Jul; 120(1):112-4. PubMed ID: 7611316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group.
    Freeman WR; Azen SP; Kim JW; el-Haig W; Mishell DR; Bailey I
    Arch Ophthalmol; 1997 Jan; 115(1):11-21. PubMed ID: 9006420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitrectomy in eyes at risk for macular hole formation.
    Jost BF; Hutton WL; Fuller DG; Vaiser A; Snyder WB; Fish GE; Spencer R; Birch DG
    Ophthalmology; 1990 Jul; 97(7):843-7. PubMed ID: 2381695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline characteristics, natural history, and risk factors to progression in eyes with stage 2 macular holes. Results from a prospective randomized clinical trial. Vitrectomy for Macular Hole Study Group.
    Kim JW; Freeman WR; el-Haig W; Maguire AM; Arevalo JF; Azen SP
    Ophthalmology; 1995 Dec; 102(12):1818-28; discussion 1828-9. PubMed ID: 9098283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CLOSING MACULAR HOLES WITH "MACULAR PLUG" WITHOUT GAS TAMPONADE AND POSTOPERATIVE POSTURING.
    Chakrabarti M; Benjamin P; Chakrabarti K; Chakrabarti A
    Retina; 2017 Mar; 37(3):451-459. PubMed ID: 27491044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atypical macular holes].
    Brüggemann A; Hoerauf H
    Klin Monbl Augenheilkd; 2008 Apr; 225(4):281-5. PubMed ID: 18401794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomographic findings of macular holes and retinal detachment after vitrectomy in highly myopic eyes.
    Ikuno Y; Sayanagi K; Oshima T; Gomi F; Kusaka S; Kamei M; Ohji M; Fujikado T; Tano Y
    Am J Ophthalmol; 2003 Sep; 136(3):477-81. PubMed ID: 12967801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vision-threatening complications of surgery for full-thickness macular holes. Vitrectomy for Macular Hole Study Group.
    Banker AS; Freeman WR; Kim JW; Munguia D; Azen SP
    Ophthalmology; 1997 Sep; 104(9):1442-52; discussion 1452-3. PubMed ID: 9307639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of full-thickness macular holes using autologous serum.
    Wells JA; Gregor ZJ
    Eye (Lond); 1996; 10 ( Pt 5)():593-9. PubMed ID: 8977788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management options for early stages of acutely symptomatic macular holes.
    Kokame GT
    Am J Ophthalmol; 2002 Feb; 133(2):276-8. PubMed ID: 11812440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic full-thickness macular hole (FTMH).
    Spiteri Cornish K; Lois N; Scott N; Burr J; Cook J; Boachie C; Tadayoni R; la Cour M; Christensen U; Kwok A
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009306. PubMed ID: 23740611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study Group.
    Kim JW; Freeman WR; Azen SP; el-Haig W; Klein DJ; Bailey IL
    Am J Ophthalmol; 1996 Jun; 121(6):605-14. PubMed ID: 8644802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autofluorescence and axial length as prognostic factors for outcomes of macular hole retinal detachment surgery in high myopia.
    Arias L; Caminal JM; Rubio MJ; Cobos E; Garcia-Bru P; Filloy A; Padron N; Mejia K
    Retina; 2015 Mar; 35(3):423-8. PubMed ID: 25170859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of macular holes that develop after retinal detachment repair.
    Moshfeghi AA; Salam GA; Deramo VA; Shakin EP; Ferrone PJ; Shakin JL; Fastenberg DM
    Am J Ophthalmol; 2003 Nov; 136(5):895-9. PubMed ID: 14597042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of unoperated macular holes.
    Casuso LA; Scott IU; Flynn HW; Gass JD; Smiddy WE; Lewis ML; Schiffman J
    Ophthalmology; 2001 Jun; 108(6):1150-5. PubMed ID: 11382645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical results of vitrectomy for idiopathic macular hole--factors affecting postoperative visual prognosis].
    Tsujikawa A; Ogura Y; Honda Y
    Nippon Ganka Gakkai Zasshi; 1995 Apr; 99(4):450-4. PubMed ID: 7741058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical findings in macular hole surgery with indocyanine green-assisted peeling of the internal limiting membrane.
    Wolf S; Reichel MB; Wiedemann P; Schnurrbusch UEK
    Graefes Arch Clin Exp Ophthalmol; 2003 Jul; 241(7):589-592. PubMed ID: 12736727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitrectomy for prevention of macular holes. Results of a randomized multicenter clinical trial. Vitrectomy for Prevention of Macular Hole Study Group.
    de Bustros S
    Ophthalmology; 1994 Jun; 101(6):1055-9; discussion 1060. PubMed ID: 8008347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Visual development of postoperative persistent macular holes with and without surgical revision].
    Schüler A; Lucke K; Bopp S
    Klin Monbl Augenheilkd; 2009 Nov; 226(11):927-32. PubMed ID: 19798626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes.
    Thompson JT; Glaser BM; Sjaarda RN; Murphy RP
    Am J Ophthalmol; 1995 Jan; 119(1):48-54. PubMed ID: 7825689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.